Wang Y, Li Z, Wan H
First Affiliated Hospital of Suzhou Medical College, Thrombosis and Hemostasis Research Unit, Jiangsu Institute of Hematology, Suzhou 215006.
Zhonghua Xue Ye Xue Za Zhi. 1998 Mar;19(3):125-8.
To identify factor IX gene mutations in patients with hemophilia B.
The coding regions, splicing junction sites and part of the 5' and 3' flanking regions of factor IX gene were screened by polymerase chain reaction (PCR) and denaturing gradient gel electrophoresis (DGGE).
Four amplified fragments showed abnormal electrophoresis patterns, and sequencing of them demonstrated four novel point mutations including a T to G transition at nucleotide 10,380 resulting in intron 3 covering the splicing site, a A to G transition at nucleotide 30,918 resulting in a substitution of Cys for Tyr at codon 266 in exon 8, and a A to C transition at nucleotide 31,007 resulting in a substitution of Pro for Thr at codon 299 in exon 8.
Detection of mutations by PCR, DGGE and sequencing was useful not only for understanding the structure function relationship of F IX, but also for the carrier detection and prenatal diagnosis.
鉴定乙型血友病患者的凝血因子IX基因突变。
采用聚合酶链反应(PCR)和变性梯度凝胶电泳(DGGE)对凝血因子IX基因的编码区、剪接连接位点以及部分5'和3'侧翼区进行筛查。
四个扩增片段显示出异常的电泳图谱,对其进行测序发现了四个新的点突变,包括第10380位核苷酸处由T向G的转换,导致内含子3覆盖剪接位点;第30918位核苷酸处由A向G的转换,导致外显子8中第266密码子处的半胱氨酸被酪氨酸取代;以及第31007位核苷酸处由A向C的转换,导致外显子8中第299密码子处的苏氨酸被脯氨酸取代。
通过PCR、DGGE和测序检测突变不仅有助于了解FIX的结构功能关系,还可用于携带者检测和产前诊断。